tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily

Ligand Pharma (LGND) Income Statement

798 Followers

Ligand Pharma Income Statement

Last quarter (Q3 2024), Ligand Pharma's total revenue was $51.81M, an increase of 57.64% from the same quarter last year. In Q3, Ligand Pharma's net income was $-7.17M. See Ligand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 152.42M$ 131.31M$ 196.25M$ 241.54M$ 163.56M$ 120.28M
Cost of Revenue
$ 9.88M$ 10.51M$ 52.83M$ 62.18M$ 30.42M$ 11.35M
Gross Profit
$ 142.54M$ 120.80M$ 143.42M$ 179.37M$ 133.14M$ 108.94M
Operating Expense
$ 158.24M$ 110.98M$ 140.38M$ 137.69M$ 177.69M$ 126.00M
Operating Income
$ -16.33M$ 11.94M$ 3.04M$ 103.85M$ 25.84M$ 807.08M
Net Non Operating Interest Income Expense
$ 7.54M$ 7.05M$ 247.00K$ -18.73M$ -19.34M$ -7.32M
Other Income Expense
$ 57.98M$ 46.78M$ 32.73M$ 12.91M$ -73.00K$ -809.67M
Pretax Income
$ 58.81M$ 63.66M$ 36.01M$ 72.20M$ -10.54M$ 796.64M
Tax Provision
$ 13.57M$ 9.84M$ 41.23M$ -4.15M$ -5.31M$ 167.34M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 46.51M$ 52.15M$ -33.36M$ 57.14M$ -2.98M$ 629.30M
Basic EPS
$ 2.61$ 3.02$ -1.98$ 2.15$ -0.11$ 20.67
Diluted EPS
$ 2.55$ 2.94$ -1.98$ 2.06$ -0.11$ 19.87
Basic Average Shares
$ 71.65M$ 17.30M$ 16.87M$ 26.66M$ 25.94M$ 30.45M
Diluted Average Shares
$ 72.51M$ 17.76M$ 16.87M$ 27.65M$ 25.94M$ 31.67M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 96.99M$ 121.49M$ 193.21M$ 199.87M$ 208.11M$ 137.35M
Net Income From Continuing And Discontinued Operation
$ 45.24M$ 52.15M$ -33.36M$ 57.14M$ -2.98M$ 629.30M
Normalized Income
$ -58.82M-----
Interest Expense
------
EBIT
$ 41.86M$ 64.32M$ 37.81M$ 91.82M$ 28.71M$ 832.38M
EBITDA
$ 68.86M$ 99.96M$ 89.18M$ 142.77M$ 56.67M$ 895.83M
Currency in USD

Ligand Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis